GALDERMA GROUP AG (GALDY) Stock Forecast & Price Target
GALDERMA GROUP AG · NYSE
$42.44-0.05 (-0.12%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for GALDY yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $42.44 current
Highest Target—
Average Target—
Lowest Target—
GALDY EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 1 analysts
Next period, 1 analysts expect GALDERMA GROUP AG to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $3.51, growing to $5.16 the year after.
REVENUE · NEXT QUARTER
$1.7B
Range $1.7B – $1.7B · 1 analysts · +14% YoY
Revenue is expected to reach $1.7B (range $1.7B – $1.7B), +13.8% year-over-year. Full-year consensus is $6.4B, rising to $7.5B next year.
GALDY stock forecast FAQ
What is GALDERMA GROUP AG's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 1 analysts. Full-year EPS is projected at $3.51, rising to $5.16 the following year.
How much revenue is GALDERMA GROUP AG expected to report next quarter?+
Consensus revenue is $1.7B (range $1.7B – $1.7B). Full-year revenue is projected at $6.4B, growing to $7.5B next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GALDY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
